Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20100119003106N38Phase 3Completed
Phase 3, randomised, double-blind trial of simvastatin in acne vulgaris, sponsored by Islamic Azad University. Primary endpoints: Reduction in inflammatory acne lesions, Change in Global Acne Grading System score and 1 more. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20100119003106N38.